Scientific Sessions
  • #AHA22
  • Virtual Experience Access
  • Sessions Posters
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Featured Exhibitors
  • Program
  • Previews
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Featured Exhibitors
  • Program
  • Previews
Resources
  • #AHA22
  • Virtual Experience Access
  • Sessions Posters
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter iconFacebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
AHA speaker dais
AHA22
Uncovering novel approaches in heart failure science
Nov 7th, 2022
Aha22 Sm 2334
AHA22
Trial results report on benefits of radial artery for CABG, use of prophylactic methylprednisolone and ECMO for patients in cardiogenic shock
Nov 7th, 2022
22 Aha Zb0087 Web
AHA22
Trials’ results compare loop and thiazide diuretics and highlight ineffectiveness of novel fibrate therapy for reducing CV risk
Nov 6th, 2022
Discussants at Scientific Sessions
Home
Late-Breaking Science announced
Sep 20th, 2022
Manesh R. Patel, MD, Chair of the Committee of the Scientific Sessions Program
AHA21
Plan your schedule now for Late-Breaking Science
Watch now
Nov 8th, 2021
-
audience
AHA22
Early ablation bests medication in treatment naïve AFib patients
Nov 9th, 2022
audience shot
AHA22
First-in-class aminopeptidase-A inhibitor fails to reduce treatment-resistant hypertension
Nov 9th, 2022
Data-driven precision medicine
Sponsored
Data-driven precision medicine
Finding and helping patients with undiagnosed or undertreated cardiovascular diseases
Oct 26th, 2022
audience shot
AHA22
Trial results shed light on tool for assessing VTE risk, routine anticoagulation for non-hospitalized COVID patients, and clinical outcomes of open vs. endovascular surgery for advanced PAD
Nov 8th, 2022
LBS 05 panelists
AHA22
Trials’ results highlight supplement ineffectiveness and potential for novel therapies to lower lipoprotein(a), reduce CKD progression
Nov 8th, 2022
audience shot
AHA22
Bivalirudin superior to unfractionated heparin in primary PCI following STEMI
Nov 8th, 2022
Panelists of the Mindful Disruption panel
Late-Breaking Science
Overcoming health disparities, health care advocates and mindfulness can better manage BP and CVD
Nov 7th, 2022
Person putting on tennis shows
AHA22
Join the Wellness Challenge at #AHA22
Download the Wellness App and use your fitness devices to compete with other attendees.
Oct 26th, 2022
Scientific Sessions attendees in lobby
Home
Join us for Scientific Sessions 2022 in Chicago or online
Welcome back to the full experience of the world’s foremost celebration of cardiovascular and brain health science!
Sep 20th, 2022
Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
Nov 19th, 2021
Lbs02 Group Blood Patel
AHA21
Update on local and global hypertension science
Late-breaking science uncovers findings about hypertension.
Nov 19th, 2021
(from left to right): Jonathan P. Piccini, MD, MHS, FAHA, and Steven A. Lubitz, MD, MPH, FAHA
AHA21
Late-Breaking Science: New information in cardiac disease
Nov 15th, 2021
(from left to right): Nasrien E. Ibrahim, MD, Stefan D. Anker, MD, PhD, and Clyde W. Yancy, MD, MSc, FAHA
AHA21
The latest science in heart failure
Nov 15th, 2021
(From left to right): Danielle Belardo, MD, Rafael Diaz, MD, and Christie Mitchell Ballantyne, MD, FAHA
AHA21
Trials’ results highlight the potential for fish oil to fight COVID-19 and MK-0616 to lower cholesterol
Nov 15th, 2021
(left to right): Jacqueline E. Tamis-Holland, MD, and Jane Armitage, FRCP, FFPH, OBE
AHA21
New drugs, indications in cardiovascular disease
Nov 15th, 2021
Elaine Hylek, MD, MPH, and Bruno Caramelli, MD, PhD
AHA21
Trials’ results suggest advancements in treatment approaches for AF and insight on the cardiac effects of coffee consumption
Nov 14th, 2021
Newsletter Card Late Breaking
AHA21
Monday's Late-Breaking Science presentations
Nov 14th, 2021
Maxresdefault 6190740f4299a
AHA21
#AHA21 highlights for Day 1
Nov 13th, 2021
Marko Banovic, MD, PhD
AHA21
Valves, veins and new viewpoints in cardiothoracic surgery
Nov 13th, 2021
Newsletter Card Late Breaking
AHA21
Sunday's Late-Breaking Science presentations
Nov 13th, 2021
Marko Banovic, MD, PhD
AHA21
Valves, veins and new viewpoints in cardiothoracic surgery
Nov 13th, 2021
Newsletter Card Late Breaking
AHA21
Sunday's Late-Breaking Science presentations
Nov 9th, 2021